Inhaled corticosteroids

DRUG5 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI), GlaxoSmithKline, Makassed General Hospital

Conditions

AsthmaLung DiseasesRespiratory Distress

Unknown Phase

Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents

CompletedNCT00114413

National Institute of Allergy and Infectious Diseases (NIAID)Asthma

Start: 2004-08-31End: 2006-11-30Updated: 2017-02-10

Prevention of Early Asthma in Kids (PEAK)

CompletedNCT00272441

National Heart, Lung, and Blood Institute (NHLBI)Asthma, Lung Diseases

Start: 2001-01-31End: 2004-09-30Updated: 2016-07-12

Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids

CompletedNCT01332344

GlaxoSmithKlineAsthma

Start: 2009-06-30End: 2010-06-30Updated: 2017-06-02

Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy

CompletedNCT01347060

GlaxoSmithKlineAsthma

Start: 2009-07-31End: 2010-04-30Updated: 2017-05-25

Inhaled Budesonide in Transient Tachypnea of the Newborn

Makassed General HospitalRespiratory Distress

Start: 2021-02-15End: 2021-08-31Target: 50Updated: 2021-03-03

Related Papers

Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.

2008-09-01294 citations

Long-term inhaled corticosteroids in preschool children at high risk for asthma.

2006-05-01620 citations